Waters Launches High-Speed Mass Spectrometer to Boost Multiomics Research
Event summary
- Waters Corporation introduced the Xevo MRT P10 Mass Spectrometer, a benchtop high-resolution QToF system with up to 20x higher MS/MS sensitivity and 2x faster acquisition speeds.
- The new system identifies up to 40% more lipids by LC-MS/MS than leading competitors, advancing lipidomics research.
- The Xevo MRT P10 MS features the DESI XS source, setting a new benchmark for throughput in high-resolution spatial analysis.
- The product will be showcased at the 74th ASMS Conference and is expected to be available globally beginning summer 2026.
The big picture
Waters' new mass spectrometer targets a critical bottleneck in multiomics research—speed and sensitivity in high-resolution analysis. The launch aligns with the growing demand for deeper biological insights across proteomics, lipidomics, and metabolomics, areas increasingly central to drug discovery and disease understanding. The instrument's capabilities could position Waters as a key enabler in next-generation biomedical research, particularly as institutions and companies scale up their omics-driven studies.
What we're watching
- Market Adoption
- How quickly academic and industry researchers will integrate the Xevo MRT P10 MS into their workflows, given its claimed performance advantages.
- Competitive Response
- Whether competitors like Thermo Fisher or Agilent will accelerate their own benchtop HRMS developments in response.
- Revenue Impact
- The pace at which Waters can convert early interest into sales, particularly in high-growth areas like multiomics and lipidomics.
Related topics